Navigation Links
WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
Date:9/7/2007

NEW YORK, Sept. 7 /PRNewswire-FirstCall/ -- Richard Gabriel, Chief Executive Officer of DNAPrint Genomics, Inc. (OTC Bulletin Board: DNAG) (http://www.dnaprint.com) will be featured in an exclusive interview with http://www.wallst.net that is scheduled to take place on September 10 at 11 a.m. EDT. The interview will be posted on http://www.wallst.net by 8 p.m. EDT on September 10.

The interview will cover topics including DNAPrint Genomics' market potential, growth initiatives, competitive edge, recent news, and milestones for which investors should watch.

To hear the interview in its entirety, visit http://www.wallst.net, and click on "Interviews." The interview can be accessed either by locating the company's ticker symbol under the appropriate exchange at the top of the "Interviews" section of the site, or by entering the company's ticker symbol in the Search Archive window on the right-hand column of the "Interviews" section.

About DNAPrint Genomics:

DNAPrint(TM) Genomics, Inc. is a developer of genomics-based products and services in two primary markets: biomedical and forensics. DNAPrint Pharmaceuticals, Inc., a wholly owned subsidiary, develops diagnostic tests and theranostic products (drug/test combinations) using the Company's proprietary ancestry-informed genetic marker studies combined with proprietary computational modeling technology. Computational Biology and Pharmacogenomics services are also offered externally to biopharmaceutical companies. The Company's first theranostic product is PT-401, a "Super EPO" (erythropoietin) dimer protein drug for the treatment of anemia in renal dialysis patients (with end stage renal disease). DNAPrint is proud of its continued dedication to developing and supplying new technological adva
'/>"/>

SOURCE Financial Filings Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Cranford, NJ (PRWEB) October 22, 2014 ... technologies and services – has been working with a ... Health and New Haven Farms Community Farming Collaborative to ... iPad-based ePRO solution. The study, which started in ... Wellness program that provides participants weekly exposure to and ...
(Date:10/22/2014)... Oct. 22, 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, announced today that ... Notice of Allowance for a composition of matter patent ... difficile program, SYN-004. This is Synthetic Biologics, first ... U.S. and adds to the Company,s extensive C. ...
(Date:10/20/2014)... 20, 2014 The report “Pharmacy ... Systems, Packaging and Labeling Systems, Table-top Counters) by ... Global Forecasts & Trends to 2019” analyzes and ... in North America, Europe, Asia-Pacific, and the Rest ... tables and 30 figures spread through 300 pages ...
(Date:10/20/2014)... , October 20, 2014 ... gastrointestinal (GI) disorders and the delivery of care has ... diseases and worrying inequalities in the provision of healthcare ... which was commissioned by United European Gastroenterology (UEG), have ... political and public awareness of the burden of GI ...
Breaking Biology Technology:myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 2Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 5
... Interleukin Genetics,Inc. (Amex: ILI ), announced today that ... August 13, 2008, at 8:30 a.m. EDT to review ... update on,recent corporate developments., To access the live ... and replay access of the teleconference,will be available on ...
... announced today that,it has updated coverage and has issued ... INO ). "The proposed merger of Inovio and VGX,would ... deliver,therapeutic agents and positions Inovio/VGX, based on further development,progress, ... gene therapy,companies," said Ross Silver, Director of Research for ...
... Inc.,(Nasdaq: NXTM ), a leading manufacturer of ... Chief Executive Officer and Robert,Brown, Chief Financial Officer, ... Where possible, a webcast of each event will ... time of each,conference., Canaccord Adams Annual ...
Cached Biology Technology:Interleukin Genetics Announces Conference Call and Webcast to Discuss Second Quarter 2008 Business Results 2Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO); $3.57 Price Target 2NxStage Announces Investor Conference Schedule 2
(Date:10/22/2014)... -- Aware, Inc. (NASDAQ: AWRE ), a leading ... for its third quarter ended September 30, 2014. ... an increase of 40% compared to $4.3 million in the ... of 2014 was $4.1 million compared to $1.0 million in ... current three month period was primarily due to: i) a ...
(Date:10/18/2014)... a sample of patients with undiagnosed, suspected genetic conditions, ... with a higher molecular diagnostic yield than traditional molecular ... JAMA . The study is being released to coincide ... , Exome sequencing, which sequences the protein­coding region of ... material present in a cell or organism), has been ...
(Date:10/17/2014)... German . To ... treating overdoses, doctors are often limited to supportive therapy such ... a combination of drugs involved. So what can be done ... pills? ETH professor Jean-Christophe Leroux from the Institute of Pharmaceutical ... this question. "The task was to develop an agent that ...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2014 Financial Results 2Aware, Inc. Reports Third Quarter 2014 Financial Results 3Aware, Inc. Reports Third Quarter 2014 Financial Results 4Aware, Inc. Reports Third Quarter 2014 Financial Results 5Aware, Inc. Reports Third Quarter 2014 Financial Results 6Aware, Inc. Reports Third Quarter 2014 Financial Results 7Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Emergency aid for overdoses 2Emergency aid for overdoses 3
... steelhead trout in hatcheries causes a dramatic and unexpectedly ... wild, a new Oregon State University study shows, and ... practices. The research, to be published Friday in ... the reproductive success of steelhead trout, an important salmonid ...
... is reined in prevented from giving up its ... presence of a protein modification that stifles any genes ... heart or other specialized tissue. But, thanks to the ... primed and poised, ready to develop into specialized body ...
... WHAT: The 2007 Prostate Cancer Foundation Scientific Retreat will ... prostate cancer. Presentations include discoveries expected to lead ... help men avoid developing prostate cancer. ... share new research on how eating common foods such ...
Cached Biology News:Salmonid hatcheries cause 'stunning' loss of reproduction 2Salmonid hatcheries cause 'stunning' loss of reproduction 3Human embryonic stem cells remain embryonic because of epigenetic factors 2Human embryonic stem cells remain embryonic because of epigenetic factors 3New prostate cancer research findings 2
... The Agilent One-Color RNA Spike-In Kit ... specifically anneal only to complementary control probes ... cross-hybridization. The spike-ins serve as a positive ... NOTE: This kit is a ...
... spatulas have been designed to save time ... those interested in eliminating the recycling and ... is individually packaged, RNase/DNase free, non-pyrogenic and ... new product number, created to easily match ...
... use spatulas have been designed to save ... for those interested in eliminating the recycling ... spatula is individually packaged, RNase/DNase free, non-pyrogenic ... a new product number, created to easily ...
... CHEMICONs Alkaline Phosphatase Detection Kit (Catalog ... tool for the phenotypic assessment of ES ... activity. Available separately from CHEMICON are ... and TRA-2-54 (Catalog Number MAB4354), which permit ...
Biology Products: